We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
We're changing the way Sapphire looks
Same platform, new visual identity. Learn more: Sapphire is becoming NHMRC Grant Management System.
NHMRC is seeking information from guideline developers about the impact of guidelines.
Guidelines represent a significant investment of public funds and volunteer labour. A growing awareness in government, and in organisations that make significant financial investments in the development of evidence-based health advice, has highlighted the importance of demonstrating the impact of their investment.
NHMRC defines the impact of research as ‘the verifiable outcomes that research makes to knowledge, health, the economy and/or society and not the prospective or anticipated effects of the research.’ While we draw on this definition to inform the discussion about guideline impact, we are aware there may be more subtleties to defining the impact of guidelines.
NHMRC is interested in discovering more about how guideline developers view impact, how they might use impact data in their process and to identify efforts made by Australian guideline developers to evaluate guideline impact. This information is of importance to NHMRC's Health Translation Advisory Committee (HTAC) which advises NHMRC on opportunities to improve health outcomes in areas relevant to clinical care, public, population and environmental health.
We invite guideline developers to provide comment through a number of Consultation questions to help us build a more informed picture of guideline impact in Australia and to work towards establishing a more suitable definition of guideline impact.
All feedback collected is de-identified and will be reported in confidence to HTAC for further advice. The information and themes collected through this exercise will also inform the scope and structure of a Guidelines for Guidelines Handbook module on Guideline Impact. This module will be released for public consultation in 2021 with an invitation to provide further comment on the content before it is finalised.
We welcome comments from anyone involved in the development of guidelines. Please send feedback and comments to clinicalguidelines@nhmrc.gov.au.
ISBN: 978-1-86496-024-2